Biochemical Modulation of 5-Fluorouracil in Colorectal Cancer
Author Information
Author(s): C Aschele, A Guglielmi, GL Frassineti, C Milandri, D Amadori, R Labianca, M Vinci, L Tixi, C Caroti, E Ciferri, E Verdi, R Rosso, A Sobrero
Primary Institution: Istituto Nazionale per la Ricerca sul Cancro
Hypothesis
Can the addition of natural beta-interferon enhance the efficacy of a regimen alternating bolus and continuous infusion of 5-fluorouracil in advanced colorectal cancer?
Conclusion
The addition of natural beta-interferon did not improve the therapeutic outcome compared to the original regimen.
Supporting Evidence
- Five complete responses and 17 partial responses were observed, resulting in a 41% response rate.
- The median time to treatment failure was 6.4 months.
- The median duration of survival was 15.0 months.
- Grade III-IV toxicity occurred in 18% of patients.
- Previous adjuvant treatment influenced the clinical response, with a 10% response rate in those who had received it.
Takeaway
Doctors tested a new treatment for colon cancer that combined two types of chemotherapy. They found that adding a special protein didn't make it work better.
Methodology
Patients received alternating cycles of bolus 5-fluorouracil and continuous infusion 5-fluorouracil, with the addition of natural beta-interferon in the bolus phase.
Potential Biases
Potential bias due to the non-randomized design and differences in patient characteristics.
Limitations
The study was not randomized, and the patient population had different prognostic factors compared to previous studies.
Participant Demographics
{"median_age":63,"gender_distribution":{"male":32,"female":24},"performance_status":{"0":29,"1":22,"2":5},"primary_site":{"colon":43,"rectum":13},"previous_adjuvant_chemotherapy":10}
Statistical Information
P-Value
0.038
Confidence Interval
95% confidence limits, 28-55%
Statistical Significance
p=0.038
Want to read the original?
Access the complete publication on the publisher's website